Risk assessment for ecotoxicity of pharmaceuticals – an emerging issue

By Kar Supratik   Roy Kunal  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 235-274

Informa Healthcare

Access to resources Recommend Favorite

Immune function testing of human pharmaceuticals: regulatory overshoot?

By van der Laan Jan Willem   van Loveren Henk  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Natural and synthetic organic compounds in the environment-a symposium report

By Ariese F.   Ernst W.H.O.   Sijm D.T.H.M.  

Environmental Toxicology and Pharmacology, Vol. 10, Iss. 3, 2001-07 ,pp. : 65-80

Elsevier

Access to resources Recommend Favorite

Metals in the Human Environment Strategic Network (MITHE-SN): The Interface of Risk Assessment, Public Policy, and Advocacy

By Hale Beverley   Ritter Len   Warner Donna  

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 2-3, 2010-01 ,pp. : 96-100

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Utility of Two Rodent Species in Carcinogenic Risk Assessment of Pharmaceuticals in Europe

By van Oosterhout J.P.J.   van der Laan J.W.   de Waal E.J.   Olejniczak K.   Hilgenfeld M.   Schmidt V.   Bass R.  

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 1, 1997-02 ,pp. : 6-17

Academic Press

Access to resources Recommend Favorite